Prohibits a carrier or fiscal intermediary from requiring the substitution of a self-administered drug for an intravenously-administered drug or drug therapy if, in the judgment of the physician of the individual diagnosed with a condition for which the drug or drug therapy has been prescribed, intravenous-administration of the drug or drug therapy is more appropriate or effective to treat the individual's condition.